Patents by Inventor Jason Rodriguez

Jason Rodriguez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160337547
    Abstract: A relay device includes a first communication portion, a second communication portion, a request message reception portion, a request command transmission portion, a request information reception portion, and a request information transmission portion. The relay device receives a request message from a mobile terminal through a first communication network, transmits a request command corresponding to the request message to the image forming apparatus through a second communication network, and transmits information containing information of an apparatus status received from the image forming apparatus to the mobile terminal.
    Type: Application
    Filed: April 13, 2016
    Publication date: November 17, 2016
    Inventors: Jason Rodriguez, Cedric Sarigumba, Cara Tilos, Maria Luisa Exaltacion
  • Publication number: 20160177585
    Abstract: A concrete depression form system and method having a rail that is readily removable from sacrificial support towers after the concrete has sufficiently cured, leaving a slab having an elevated interior slab surface and a depressed or lower exterior slab surface, the support towers being structured such that concrete flow is only minimally impeded and such that no portion of the support towers extends outwardly from the slab surfaces.
    Type: Application
    Filed: December 18, 2015
    Publication date: June 23, 2016
    Inventors: Miguel E. Baena, Peter Rodriguez, Jason Rodriguez, Dennis A. Dohogne
  • Publication number: 20060210536
    Abstract: The invention relates to compositions and methods for modulating cell signaling mediated by signal transducers and activators of transcription (STAT). The compositions target cellular STAT3 and STAT1 protein, particularly STAT3, for degradation via the ubiquitination pathway. Thus, the STAT inhibiting agents are useful for inhibiting STAT mediated signal transduction events, such as responses to IL6 and v-Src, any may be applied to treating diseases associated with activated STAT proteins, particularly STAT3 activity, such as cell proliferative disorders, inflammatory reactions, and autoimmune conditions.
    Type: Application
    Filed: April 19, 2004
    Publication date: September 21, 2006
    Inventors: Curt Horvath, Jason Rodriguez, Christina Ulane, Jean-Patrick Parisien